siRNA, Anti-CAPZA2, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT01562WQ-2OMe)

The product SIRGT01562WQ-2OMe is a type of small interfering RNA (siRNA) that targets CAPZA2 gene and regulates the expression of gene. The siRNA interferes with the expression of CAPZA2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_006136.2
Alternative Names CAPPA2; CAPZ
Related Diseases Digestive System Diseases, Neoplasms
Purification HPLC
Target Gene
Gene ID 830
Uniprot ID P47755
Sub Cat Target Species Modification Scale  
SIRGT02562WQ-2F CAPZA2 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT03562WQ-2MOE CAPZA2 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT04562WQ-LNA CAPZA2 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT01562WQ-RB CAPZA2 Human Ribo-modified Inquiry
SIRGT02562WQ-BB CAPZA2 Human Backbone-modified Inquiry

Related Products